PV Vaccines May Not Be Safe And Effective As Promised: CBCD Warns the Public
The CBCD believes that the arguments regarding the long-term benefits and safety of the HPV vaccines appear
to be resting on unproven assumptions.
If your doctor belongs to our network of doctors, you are entitled to a discount. When ordering, please tell us the name of your doctor and we will check for you.
We accept all types of credit cards (credit, debit, pre-paid, etc.). Sorry, we don't accept other modes of payment.
We can also take your order over the phone. Call us if you would like to use this option.
To keep your privacy, your bank or credit card statements will only show the name of our parent company, not the product.
For your security, we will never call you and ask for your credit card number, or personal information.
See more details about Gene-Eden-VIR/Novirin in Package Insert.
Call us and ask about promotions
The Center for the Biology of Chronic
Disease (CBCD) has just learned that according to a paper published in the
reputable journal, Current Pharmaceutical Design, "... the widespread optimism
regarding HPV vaccine's long-term benefits appears to rest on a number of
unproven assumptions (or such which are at odds with factual evidence) and
significant misinterpretation of available data."
The paper, written by authors Tomljenovic
L, Shaw CA, and Spinosa JP was published on September 24th, 2012. 
The paper went on to note: "The claim that
HPV vaccination will result in approximately 70% reduction of cervical cancers
is made despite the fact that the clinical trials data have not demonstrated
to date that the vaccines have actually prevented a single case of cervical
cancer (let alone cervical cancer death), nor that the current overly
optimistic surrogate marker-based extrapolations are justified."
The CBCD finds the authors' statements highly significant.
However, the CBCD would like to emphasize
that it is not against vaccinations in general, although the Center has come
out against the HPV vaccine in particular ... largely due to its lack of
In addition, the FDA and
Merck pharmaceuticals have admitted to the presence of foreign DNA fragments
in the vaccine which, the CBCD views as dangerous.
In fact, Gardasil (and Cervarix) are both
very limited in the protection they allegedly provide. Neither vaccine is a
cure for HPV.
Thus, while the world waits for a cure, the
CBCD would like to call attention to an HPV remedy that helps the immune
system target the latent HPV.
"The key to your health is to reduce the
level of latent viruses in your body to harmless levels." - Dr. Hanan
The name of that HPV remedy is
Gene-Eden-VIR. It is a scientifically designed, all natural product that helps the immune system
maintain a low concentration of the latent Human
Gene-Eden-VIR is effective against
the latent Human Papillomavirus (HPV). Each ingredient was chosen through a
scientific approach. polyDNA scientists scanned thousands of scientific and
medical papers published in various medical and scientific journals around the
world to identify safe and effective natural ingredients that
target the latent HPV.
Gene-Eden-VIR is safe. There
are no reports of side effects, and it has been on the market for over three
years. Each capsule contains a patented formula of five all natural
ingredients including selenium, camellia sinesis extract, quercetin,
cinnamomum extract, and licorice extract. In addition, each bottle is GMP
The public can access the scientific
papers on the ingredients of Gene-Eden-VIR on
Gene-Eden-VIR is sold online through the
Gene-Eden website. Each bottle of Gene-Eden-VIR (a one
month's supply) costs $42.99.
Ordering Gene-Eden-VIR is
secure and confidential.
To learn more about Gene-Eden-VIR, the only
product on the market today that helps the body maintain a low level of the
latent Human Papillomavirus (HPV), and that is scientifically backed by
published material, visit the Gene-Eden-VIR website.
Note: This press release was first issued by The Center for the
Biology of Chronic Disease (CBCD), a not-for-profit organization that specializes
in researching the biology of foreign DNA.